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Abstract
Background: Non-compliance to blood pressure-lowering medication is a major reason for poor control of 
hypertension worldwide. We assessed the level of compliance to anti-hypertensive therapy and identified factors 
contributing to poor compliance among hypertensives in Kano.
Methodology: Three hundred and sixty outpatients were interviewed using a pre-tested, structured, mostly closed 
ended questionnaire in Murtala Mohammed Specialist Hospital in Kano, Nigeria.
Results: Good compliance with drug treatment was observed in 54.2% of the respondents and poor compliance 
among the remainder. Poor compliance was found to be mainly due to ignorance on need for regular treatment 
(32.7%), lack of funds to purchase drugs (32.7%) and side effects of drugs (12.1%). Patients with formal education, 
and higher monthly income were more compliant to treatment. In addition, those on single drugs were more compliant 
compared to those on two or more drugs. Poor compliance was found to be mainly due to ignorance and lack of 
funds to purchase drugs.
Conclusion: Based on the findings of this study, there is a need for launching a comprehensive approach involving 
health care providers, patients and the general public to educating patients on the need to take their drugs regularly 
and in the manner prescribed. Doctors should consider the financial status of their patients in prescribing anti-
hypertensive drugs to enable affordability. Prices of anti-hypertensive drugs should be subsidized where possible. 
Prescribing an effective, inexpensive, single dose daily medication with minimal side effects will improve patient 
compliance considerably.
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Developing countries undergoing epidemiological 
transition face the double burden of communicable 
and non-communicable diseases. Of the latter, 
hypertension is one of the most important treatable 
causes of mortality and morbidity. Although safe and 
effective drugs are available, the management of 
hypertension is still far from optimal especially in the 
1developing countries . A major factor accounting for 
inadequate treatment of hypertension is poor 
1, 2compliance.  Compliance can be defined as the 
degree to which the patient conforms to medical 
advice about lifestyle and dietary changes as well as 
to keeping appointments for follow up and taking 
treatment as prescribed. This can be expressed 
quantitatively as the percentage of prescribed doses 
that have been taken. Compliance can be evaluated 
4in several ways . These include pharmacological 
measures (determination of serum and urinary 
concentrations of drugs or using biological markers 
integrated into the tablets); clinical measures (clinical 
judgement of the doctor, evaluation of promptness for 
appointments and the use of questionnaires); and 
physical measures (verifying prescription renewals, 
counting the remaining pills or pill counting systems). 
Although, there is no gold standard allowing precise 
5measurement of compliance , the electronic pill 
counter or MEMS (Medication Event Monitoring 
System) may be considered as the best existing 
6system for measurement of compl iance . 
Pharmacological methods also have a higher 
7sensitivity and specificity  but remain difficult to use in 
standard practice. 
Poor compliance is especially common when a patient 
has poor knowledge, understanding, and perception 
of hypertension or when a complex anti-hypertensive 
8drug regime is prescribed . It is usual to consider 
patients to be sufficiently compliant with their 
treatment when they take at least 80% of their 
3, 9,  10prescribed anti-hypertensive drugs . In 
outpatients, compliance to anti-hypertensive 
11-13medication ranges from 20% to 80%.
Nigeria has a high prevalence of hypertension in 
Nigeria with Kano having the highest prevalence 
 rates.  The observed high incidence of complications 
even among those on treatment due to poor 
compliance, explain the need for more awareness and 
16
 immediate adjustment in the management pattern 
 2with emphasis on compliance .
The aim of this study was to assess the level of 
compliance to anti-hypertensive therapy and identify 
factors, which contribute to poor treatment 
compliance among hypertensives in Kano. 
Methodology
Study setting
Murtala Mohammed Specialist Hospital, Kano, 
owned by Kano State is the largest state government-
owned hospital in northern Nigeria and has the 
highest patients' attendance in the region. Medical, 
surgical, obstetric, laboratory, radiology and 
physiotherapy services are offered in the different 
departments of the hospital. The hypertension clinic is 
run once in a week for male patients and once in a 
week for female patients by medical doctors in the 
department of Medicine. The hospital serves mainly 
residents in Kano, especially those from the 
metropolis. Patients from neighbouring states and 
countries such as Katsina state, Jigawa state, 
Zamfara state, Niger republic and Mali also attend the 
hospital.
Methods
A cross-sectional study design was used to study a 
population of adult patients attending the 
hypertension clinic of Murtala Specialist Hospital, 
rd thKano from 3  May to 28  June, 2004.  A sample size of 
360 was obtained using an appropriate statistical 
formula for estimating minimum sample size in health 
14studies  and the prevalence of poor compliance as 
found in a study on awareness of hypertension in a 
15Nigerian tertiary health institution . The sample 
selection was done over a period of six weeks with 30 
patients selected by systematic sampling from a 
listing on each of the clinic days for male and female 
patients until 180 male and the same number of 
female patients were selected.
The selected patients were interviewed using a pre-
tested, structured, mostly closed- ended 
questionnaire after obtaining informed consent from 
the participants. Information obtained included socio-
demographic characteristics of respondents, 
regularity of patient's attendance at the hypertension 
clinic; patient's reported compliance with prescribed 
drugs and reasons for non compliance. Patients’ 
compliance were classified using the following 
4criteria : good compliance included regular 
attendance at follow-up clinics and obtaining and 
taking all drugs prescribed, taking the drugs in a day 
as prescribed, taking drugs for at least 6 to 7 days in a 
week. Poor compliance referred to irregular 
attendance at follow-up clinics, inability to obtain 
drugs regularly, not taking drugs in a day as 
prescribed, taking drugs for less than 6 days in a 
week. The fourth section asked about factors 
 militating against good compliance.
Data was analysed using Epi-Info version 6.0 
statistical software (CDC Atlanta, Georgia, U.S.A). 
Absolute numbers and simple percentages were used 
to describe categorical variables. Similarly, 
quantitative variables were described using measures 
of central tendency (mean, median) and measures of 
dispersion (range, standard deviation) as appropriate. 
The Chi-square test was used in assessing the 
significance of associations between categorical 
groups. A p-value of 0.05 or less was considered 
statistically significant.
Results
The ages of respondents ranged between 20 to 94 
years with a mean age (SD) of 533.6 years. The 
majority of respondents (49.4%) were between 50-64 
years of age.  
There were equal number of men and women in the 
study. Majority of respondents (88.6%) lived within 
Kano metropolis while the rest lived in nearby rural 
areas or came from neighbouring states. Only 27% of 
respondents had formal education (primary, 
secondary and tertiary education) and majority of them 
earned less than N10, 000 (about twice the national 
minimum wage) per month. The Hausa ethnic group 
constituted the majority (82.5%) of the respondents, 
followed by Fulani (9.2%), Kanuri (4.7%), Yoruba 
(1.7%) and Igbo (0.5%). The remaining (1.9%) were 
from other minority Nigerian tribes including Tiv, Egbira 
and Babur. Most of the respondents (73.6%) were 
married while the rest were widowed, divorced or 
separated. Only 0.8% was single. Majority (97.5%) of 
the patients were Muslims while the remaining 2.5% 
were Christians. 
Table I shows that 54.2% of respondents had good 
compliance with treatment whereas the remaining 
45.8% had poor compliance. Majority of the patients 
were regular clinic attendees while a quarter were 
irregular as shown in Table 2.  
Poor compliance was found to be mainly due to 
ignorance on need for regular treatment (32.7%) and 
lack of funds to purchase drugs (32.7%). Other factors 
included side effects of drugs (12.1%), non-availability 
of drugs in patients' place of domicile (8.0%), 
exhaustion of prescribed drugs and non-attendance at 
scheduled clinic day (4.8%), normal blood pressure 
during the previous clinic visit (3.6%), forgetfulness 
(3.0%), and busy schedule 
(1.8%).
Seventy two (74.2%) of the 97 respondents who had 
formal education were compliant with their treatment 
compared to only 123 of the 263 (47.0%) respondents 
without formal education. This difference was 
2 statistically significant (X =21.5 df=1 P<0.01). 
Similarly, a higher proportion 113 (89.7%) of those with 
monthly income of above 10, 000 Naira were 
compliant with their treatment compared to 82 (35.0%) 
of those whose monthly income was less than 10,000 
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 whose monthly income was less than 10,000 Naira 
2 (X =98.5 df =1 P<0.01). Similarly, a significantly 
higher proportion 97 (84.3%) of patients who were on 
one or two types of drugs showed better compliance 
compared to 98 (40.0%) of those being treated with 
2more than two types of drugs (X = 61.9, df = 1 P 
<0.01).
Compliance level              Frequency   Percentage (%) 
 
 
Poor    165                                                45.8 
 
Good    195                                                54.2 
 
Total     360      100 
Table I:  Level of compliance with drugs among hypertensive patients
Discussion
This study revealed that almost half of the 
hypertensive patients in Murtala Mohammed 
specialist hospital had poor compliance with respect 
to drug treatment. Isezuo and Opara reported similar 
findings in a study on awareness of hypertension in 
Usman Danfodio teaching hospital Sokoto in 
15northern Nigeria . Furthermore, Olubodun and 
19colleagues  reported low compliance among all 
socio-economic groups in Ibadan. They found that 
59.5% of the patients were not informed by their 
physicians of the need for continued and regular 
treatment and follow-up. In another study in 
Seychelles to monitor one-year compliance to anti 
hypertension medication in a general hospital setting 
 the prevalence of poor compliance was found to be 
1746%.  But in a study carried out in a university 
hospital in Switzerland, poor compliance was 
16observed in only 20.2% of patients . Similarly, a 
15Japanese study  found that 63.8% of their patients 
reported taking 95-100% of prescribed drugs. 
Medication compliance was related to the frequency 
and timing of dosing rather than to the number of 
 drugs. Once daily regimens was found to have better 
compliance than three times daily ones. Furthermore, 
medication compliance was greatest for morning 
dosing, second greatest for evening doses and least 
for noon. This could be explained by the fact that 
patients are usually at home and less busy during the 
peak compliance periods as opposed to midday. In 
Bangladesh and India on the other hand a WHO 
 study found satisfactory compliance in only 25% of 
18patients . These findings seem to suggest that 
compliance is not unrelated to awareness and 
standard of living of people. Our finding of better 
compliance among the educated and those with 
higher incomes tend to support this point. 
Majority of the patients in this study attend 
hypertension clinic regularly. The observed good 
compliance among regular clinic attendees is not 
surprising since they are also more likely to follow 
other instructions.
The observed association between poor compliance, 
ignorance and lack of funds for the purchase drugs 
were also reported by Isezuo and Opara as being 
 responsible for poor compliance in a study among 
hypertensive patients in Usman Danfodio teaching 
15hospital, Sokoto.  Other factors not as important as 
these first two include side effects of drugs, non-
availability of drugs in patients' place of domicile, 
exhaustion of prescribed drugs before the next 
appointment, normal blood pressure during the 
previous clinic visit, forgetfulness, and busy 
Table 2: Regularity of clinic attendance among hypertensive patients 
 
 
Regularity   Frequency   Percentage (%) 
 
Regular                                         267                                             74.2 
 
Not regular       93                   25.8 
 
 
Total         360                                              100.0 
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 responsible for poor compliance in a study among 
hypertensive patients in Usman Danfodio teaching 
15hospital, Sokoto.  Other factors not as important as 
these first two include side effects of drugs, non-
availability of drugs in patients' place of domicile, 
exhaustion of prescribed drugs before the next 
appointment, normal blood pressure during the 
previous clinic visit, forgetfulness, and busy 
schedule. The lower compliance among those on 
more than two medications compared to those on 
fewer medications has also been reported by other 
16 19   workers . The report from Ibadan also identified 
economic constraints, use of alternative treatment, 
frustrations with daily drug ingestion and feeling of 
well being as impediment to compliance. Similar 
findings were reported from studies of compliance 
16among hypertensives in Switzerland  and 
17Seychelles  respectively.  Schroeder and 
21   colleagues found during a systematic review of 
effective interventions for improved compliance that 
simplifying dosage regimens, improved doctor-
patient communication and motivational strategies in 
combination was more effective than patient 
22education alone. Similarly, Moore  reported that 
optimal control of hypertension was impeded by poor 
patient-physician communication, excessive dietary 
sodium, and cost of anti-hypertensive medication and 
laboratory studies.
Based on the findings of this study there is a need for 
launching a comprehensive approach involving 
health care providers, patients and the general public 
especially with the aim of educating patients on the 
need to take their drugs regularly and in the manner 
prescribed. Doctors should consider the financial 
status of their patients in prescribing anti-
hypertensive drugs to enable affordability. Prizes of 
anti-hypertensive drugs should be subsidized where 
possible. Prescribing an effective, inexpensive, one 
daily medication with minimal side effects will improve 
patient compliance considerably.
Table 3: Factors responsible for poor drug compliance among patients 




Factors responsible for          Frequency   Percentage (%) 
Poor compliance 
 
Absence of symptoms                  56   34.0 
Lack of funds to purchase drugs     54   32.7 
Side effect of drugs              20   12.1 
Non-availability of drugs      13     8.0 
Exhaustion of prescribed drugs       8     4.8 
Normal blood pressure during       6     3.6  
    Previous clinic visit 
Forgetfulness         5     3.0 
Busy schedule         3     1.8 
 
Total      165   100 
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